Pictet - Biotech - HR EUR
LU0190162189
Pictet - Biotech - HR EUR/ LU0190162189 /
NAV02/10/2024 |
Chg.-2.8600 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
489.7400EUR |
-0.58% |
reinvestment |
Equity
Worldwide
|
Pictet AM (EU) ▶ |
Stratégie d'investissement
To increase the value of your investment while seeking to achieve a positive social impact. Reference Index MSCI AC World (USD), an index that does not take into account environmental, social and governance (ESG) factors. Used for risk monitoring, performance objective and performance measurement. Portfolio Assets The Compartment mainly invests in equities of companies operating in the medical biotechnology sector. The Compartment may invest worldwide, including in emerging markets and Mainland China, although most of investments are concentrated in the United States of America and Western Europe.
In actively managing the Compartment, the investment manager uses a combination of market and fundamental company analysis to select securities that it believes offer favourable growth prospects at a reasonable price.The investment manager considers ESG factors a core element of its strategy by seeking to invest mainly in economic activities that contribute to a social objective whilst avoiding activities that adversely affect society or the environment. Voting rights are methodically exercised and there may be engagement with companies to positively influence ESG practices. For further information, please refer to our exclusion framework in the Responsible Investment policy*, SFDR product category Article 9. The portfolio composition is not constrained relative to the benchmark, so the similarity of the Compartment's performance to that of the benchmark may vary.
Objectif d'investissement
To increase the value of your investment while seeking to achieve a positive social impact. Reference Index MSCI AC World (USD), an index that does not take into account environmental, social and governance (ESG) factors. Used for risk monitoring, performance objective and performance measurement. Portfolio Assets The Compartment mainly invests in equities of companies operating in the medical biotechnology sector. The Compartment may invest worldwide, including in emerging markets and Mainland China, although most of investments are concentrated in the United States of America and Western Europe.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Biotechnology |
Benchmark: |
MSCI AC World (USD) |
Début de l'exercice: |
01/10 |
Dernière distribution: |
- |
Banque dépositaire: |
Bank Pictet & Cie (Europe) AG, succursale de Luxembourg |
Domicile: |
Luxembourg |
Permission de distribution: |
Austria, Germany, Switzerland, United Kingdom, Luxembourg, Czech Republic |
Gestionnaire du fonds: |
Tazio Storni, Lydia Haueter, Marco Minonne, Eugénio Martin-Fougeroux |
Actif net: |
1.59 Mrd.
USD
|
Date de lancement: |
30/06/2004 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
3.00% |
Frais d'administration max.: |
2.30% |
Investissement minimum: |
0.00 EUR |
Deposit fees: |
0.05% |
Frais de rachat: |
1.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
Pictet AM (EU) |
Adresse: |
6B, rue du Fort Niedergruenewald, 2226, Luxemburg |
Pays: |
Luxembourg |
Internet: |
www.am.pictet/de/germany
|
Pays
United States of America |
|
85.24% |
Netherlands |
|
7.57% |
Denmark |
|
3.79% |
Canada |
|
1.68% |
Cash |
|
1.33% |
France |
|
0.38% |
Global |
|
0.01% |
Branches
Healthcare |
|
82.31% |
IT/Telecommunication |
|
14.71% |
Cash |
|
1.33% |
Autres |
|
1.65% |